Skip to main content Help with accessibility Skip to main navigation

Recommendations

This section contains a list of the policy recommendations of the Pan Mersey Area Prescribing Committee.

Reviews of the new medicines have been conducted by our pharmacists using a number of resources including National Institute for Health and Clinical Excellence (NICE) which is a Special health Authority (SHA) set up in 1999. It is used to give advice to the NHS on best clinical practice including the clinical and cost effectiveness of drugs and other treatments.

Definitions and criteria for the categorisation of medicines

Legacy Merseyside
New Cheshire and Merseyside

Transition of Commissioning Policies

On 1st July 2022 NHS Cheshire and Merseyside Integrated Care Board (ICB) became the new statutory body responsible for ensuring health care services are available to meet the reasonable needs of the people of Cheshire & Merseyside.

Until such time as a single suite of commissioning policies can be developed and adopted, NHS Cheshire and Merseyside will continue to adopt and operate the CCG policies it has inherited at Place/borough level, which means that there will be no immediate change in commissioning policy for local people resident in those Places/boroughs from what was in place prior to 1st July 2022.

NHS Cheshire and Merseyside Commissioning Policies

 

Documents

Date Added: 22 - Oct - 2020

The Pan Mersey Area Prescribing Committee recommends the prescribing of NALDEMEDINE tablets (Rizmoic®▼) for the treatment of opioid-induced constipation in accordance with NICE TA651.

Date Added: 25 - Sep - 2019

The Pan Mersey Area Prescribing Committee recommends the prescribing of NALMEFENE (Selincro®) within its marketing authorisation, as an option for reducing alcohol consumption in adults with alcohol dependence, in line with NICE TA325.

Refer to Pan Mersey formulary for RAG status for each individual CCG.

Static

Body System:
Date Added: 28 - Jul - 2015

The Pan Mersey Area Prescribing Committee recommends the prescribing of NALOXEGOL Tablets (Moventig®▼) as an option for treating opioid induced constipation in adults in accordance with NICE TA345 (22nd July 2015).

Static

Date Added: 04 - Aug - 2023

The Cheshire and Merseyside Area Prescribing Group does not currently recommend the prescribing of NETARSUDIL-LATANOPROST eye drops (Roclanda®▼) for open-angle glaucoma or ocular hypertension.

Body System:
Date Added: 25 - Jun - 2024

The Cheshire and Merseyside Area Prescribing Group Policy Statement for NICE-approved anti-VEGF drugs and intravitreal corticosteroids used in Ophthalmic Medical Retinal conditions.

NHS Cheshire and Merseyside APPROVED

Body System:
Date Added: 19 - Dec - 2019

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of NICOTINE inhaler (Voke®) for nicotine dependence.

Body System:
Date Added: 29 - Jun - 2023

The Cheshire and Merseyside Area Prescribing Group recommends the prescribing of NIRMATRELVIR plus RITONAVIR tablets, SOTROVIMAB solution for infusion and TOCILIZUMAB solution for infusion  by specialists only, for treating COVID-19 in accordance with NICE TA878.

NHS Cheshire and Merseyside APPROVED